Fred Alger Management, LLC Kodiak Sciences Inc. Transaction History

Fred Alger Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$45.05 - $59.27 $225,250 - $296,350	-5,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$42.74 - $66.25 $64,110 - $99,375	1,500 Added 42.86%	5,000 $271,000
Q1 2020 May 15, 2020	BUY	$38.18 - $73.95 $133,630 - $258,825	3,500 New	3,500 $167,000

39M

6.5K

5.8K

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $417M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Fred Alger Management, LLC with notifications on news.